REFERENCES
- Romero F, Rodríguez-Iturbe B, Parra G, González L, Herrera-Acosta J, Tapia E. Mycophenolate mofetil prevents the progression of renal failure induced by 5/6 renal ablation in rats. Kidney Int 1990; 55: 945–955, [CSA]
- Tapia E, Franco M, Santamaría J, Zafra I, Quiroz Y, Rodríguez-Iturbe B, Herrera-Acosta J. Mycophenolate mofetil prevents arteriolopathy and renal injury in subtotal ablation despite persistent systemic hipertensión. Kidney Int 2003; 63: 994–1002, [INFOTRIEVE], [CROSSREF], [CSA]
- Fujihara CK, Malheiros DM, Zatz R, Noronha ID. Mycophenolate mofetil attenuates renal injury in the rat remnant kidney. Kidney Int 1998; 54: 1510–1519, [INFOTRIEVE], [CROSSREF], [CSA]
- Fujihara CK, Noronha IL, Malheiros I, Antunes GR, de Oliveira IB, Zatz R. Combined mycophenolate mofetil and losartan therapy arrests established injury in the remnant kidney. J Am Soc Nephrol 2000; 11: 283–290, [INFOTRIEVE], [CSA]
- Remuzzi G, Zoka G, Gagliardini E, Corna D, Abbate M, Benigni A. Combining an antiproteinuric approach with mycophenolate mofetil fully suppresses progressive nephropathy of experimental animals. J Am Soc Nephrol 1999; 10: 1542–1549, [INFOTRIEVE], [CSA]
- Ruggenenti P, Schieppatu A, Remuzzi G. Progression, remission, regression of chronic renal disease. Lancet 2001; 357: 1601–1608, [INFOTRIEVE], [CROSSREF], [CSA]
- Fogo A, Breyer JA, Smith MC, Cleveland WH, Agodoa L, Kirk KA, Glassock R. Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study Kidney Disease (AASK) Trial. Kidney Int 1997; 51: 244–252, [INFOTRIEVE], [CSA]
- Mazzuchi N, Schwedt E, Fernandez JM, Cusumano AM, Ancao MS, Poblete H, Saldana-Arevalo M, Espinosa NR, Centurion C, Castillo H, Gonzalez F, Milanes CL, Infante M, Ariza M. Latin American registry of dialysis and renal transplantation: 1993 Annual Dialysis Data Registry. Nephrol Dial Transplant 1997; 12: 2521–2527, [INFOTRIEVE], [CROSSREF], [CSA]
- Zucchelli P, Zuccalla A. Recent data on hypertension and progressive renal disease. J Human Hypertens 1996; 10: 679–682, [CSA]
- Caetano ER, Zatz R, Saldanha LB, Praxedes JN. Hypertensive nephrosclerosis as a relevant cause of chronic renal failure. Hypertension 2001; 38: 171–176, [INFOTRIEVE], [CSA]
- Rodríguez-Iturbe B, Pons H, Herrera-Acosta J, Jonson RJ. The role of immunocompetent cells in non-immune renal diseases. Kidney Int 2001; 59: 1626–1640, [CROSSREF], [CSA]
- Romero F, Rodríguez-Iturbe B, Pons H, Parra G, Quiroz Y, Rincón J, González L. Mycophenolate mofetil reduces cholesterol-induced atherosclerosis in the rabbit. Atherosclerosis 2000; 152: 127–133, [INFOTRIEVE], [CROSSREF], [CSA]